WILMINGTON, DE / ACCESSWIRE / February 1, 2023 / Transparency Market Research Inc. - The global Catheter-related Bloodstream Infections Market size stood at US$ 1.3 Bn in 2021 and is expected to surpass the value of US$ 2.0 Bn by 2031. The market is anticipated to expand at a CAGR of 5.1% between 2022 and 2031. The global catheter-related bloodstream infections market value is driven by the increasing prevalence of chronic illnesses, the aging population, and the rise in the number of invasive medical operations. Growing demand for catheterization among patients is further anticipated to drive market demand.
For market participants, the increase in the usage of cutting-edge technology and solutions for CRBSI infection prevention and treatment, including catheters with antimicrobial coatings and enhanced diagnostic techniques, is creating significant growth potential.
Leading companies are putting efforts into developing advanced, safe, and affordable products. Government programs aimed at enhancing the safety of patients and raising awareness about CRBSIs amongst patients and healthcare professionals are projected to accelerate market development.
Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority):
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77630
Key Findings of Market Report
- Based on treatment type, the anti-microbial agent segment held the largest market share of the global industry in 2021 at more than 75%. This trend is anticipated to prevail between 2022 and 2031. Anti-microbial medicines such as antibiotics, treat catheter-related bloodstream infections. This is done by eradicating or preventing the development of bacteria that have settled on the catheter or have gone into the bloodstream through the catheter. These medications can be used intravenously, topically, or orally. The use of antimicrobial agents is expected to increase, thereby driving the global market.
- Based on the distribution channel, the hospital pharmacies segment dominated the market in 2021. Most patients opt for hospital pharmacies due to the ease of treatment and accessibility of medications provided in hospitals. Additionally, more patients are visiting hospital pharmacists for a proper diagnosis and due to the availability of several solutions for treating catheter-related bloodstream infections. As a result, in 2021, the hospital pharmacies segment held about 55.0% share of the global catheter-related bloodstream infections market.
Global Catheter-related Bloodstream Infections Market: Growth Drivers
- The risk of infection rises as more patients undergo invasive medical procedures, such as operations and cancer treatments requiring catheters. In light of this, there is a greater demand for services and products that deal with the treatment and prevention of these illnesses. Long-term catheter use raises the probability of infection. Therefore, an increase in invasive medical procedures is a major factor driving industry growth.
- The rise in the geriatric population is anticipated to drive business opportunities in the global catheter-related bloodstream infections market. Between 2000 and 2050, a projected increase of 22% in the global population over the age of 60 is likely, up from the current 11%. According to projections, there will be 2.1 billion individuals over the age of 60 by 2050, up from 605 million currently. As people become older, the prevalence of chronic illnesses such as heart disease and diabetes increases. Given that older people are more likely to need invasive medical treatments, the rise in the aging population is a major growth driver for the global catheter-related bloodstream infections market.
Buy this Premium Research Report | Immediate Delivery Available -https://www.transparencymarketresearch.com/checkout.php?rep_id=77630<ype=S
Global Catheter-related Bloodstream Infections Market: Regional Landscape
- In 2021, North America accounted for the largest share of the global catheter-related bloodstream infections market, based on industry data. This trend is anticipated to prevail during the forecast period largely due to technological advancements in the healthcare industry to treat blood-related infections and the existence of robust healthcare infrastructure. The market in North America is being driven by an increase in the number of Americans and Canadians who suffer from catheter-related blood infections, particularly the geriatric population.
Global Catheter-related Bloodstream Infections Market: Key Players
Some of the key market players are
- Glenmark Pharmaceuticals Ltd
- Xellia Pharmaceuticals Ltd
- Fresenius Medical Care
- Merck & Co., Inc.
- Geistlich Pharma AG
- TauroPhar GmbH
Ask for References -
https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=77630
Global Catheter-related Bloodstream Infections Market: Segmentation
Treatment Type
- Anti-microbial Agents
- Antibiotic Lock Therapy
Source of Infection
- Coagulase-negative Staphylococcus
- S. aureus
- Enteric Gram-negative Bacilli
- Yeasts
- Enterococci & Streptococci
- Pseudomonas
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
Modernization of healthcare in terms of both infrastructure and services has pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Ischemia Reperfusion Injury Therapeutics Market
Acute Lung Injury Treatment Market
Small Cell Lung Cancer (SCLC) Therapeutics Market
Lung Disease Therapeutics Market
About Transparency Market Research
Transparency Market Research, a global market research company registered in Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll-Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
SOURCE: Transparency Market Research Inc.
View source version on accesswire.com:
https://www.accesswire.com/737666/Catheter-related-Bloodstream-Infections-Market-to-Expand-at-a-CAGR-of-51-during-the-Forecast-Period-Reveals-Transparency-Market-Research-Inc-Study
